Similar articles

• [Utility and specificity of markers of breast cancer].

  Hurlimann J. Hurlimann J. Arch Gynecol Obstet. 1990;247 Suppl:S86-90. Arch Gynecol Obstet. 1990. PMID: 2085280 Review. French. No abstract available.
• Histologic markers and long-term prognosis in breast cancer.

  Burtness BA. Burtness BA. Cancer J Sci Am. 1997 Jul-Aug;3(4):211-2. Cancer J Sci Am. 1997. PMID: 9263626 No abstract available.
• Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype.

  Gong Y. Gong Y. Semin Oncol. 2008 Feb;35(1):33-40. doi: 10.1053/j.seminoncol.2007.11.014. Semin Oncol. 2008. PMID: 18308144 Review.
• Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.

  Ribeiro-Silva A, Ribeiro do Vale F, Zucoloto S. Ribeiro-Silva A, et al. Am J Clin Pathol. 2006 Apr;125(4):512-8. doi: 10.1309/D744-C4NM-15J3-B00D. Am J Clin Pathol. 2006. PMID: 16627261
• [Tissue-based markers of prognosis in breast cancer].

  Kreipe H, von Wasielewski R. Kreipe H, et al. Verh Dtsch Ges Pathol. 2005;89:52-8. Verh Dtsch Ges Pathol. 2005. PMID: 18035673 German.